Abbott Laboratories (ABT) Dividends payables (2009 - 2026)

Abbott Laboratories has disclosed Dividends payables across 18 years of filings, most recently posting $1.1 billion for Q1 2026.

• Dividends payables for Q1 2026 came in at $1.1 billion, up 6.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 6.59% YoY), and the FY2025 annual result was $1.1 billion, up 7.13% from the prior year.
• Dividends payables came in at $1.1 billion for Q1 2026 at Abbott Laboratories, roughly flat from $1.1 billion in the prior quarter.
• In the past five years, Dividends payables ranged from a high of $1.1 billion in Q1 2026 to a low of $820.0 million in Q3 2022.
• The 5-year median for Dividends payables is $956.0 million (2024), against an average of $950.4 million.
• Across the five-year window, Dividends payables advanced 2.87% in 2022 and rose 8.24% in 2024, its largest moves.
• Abbott Laboratories' Dividends payables stood at $887.0 million in 2022, then increased by 7.67% to $955.0 million in 2023, then increased by 7.23% to $1.0 billion in 2024, then grew by 7.13% to $1.1 billion in 2025, then rose by 0.27% to $1.1 billion in 2026.
• The last three Dividends payables figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.